Phase II study of FK 506 for allogeneic bone marrow transplantation.
Masaoka
T
T
Fifth Department of Internal Medicine, Center for Adult Diseases, Osaka, Japan.
Shibata
H
H
Kakishita
E
E
Kanamaru
A
A
Takemoto
Y
Y
Moriyama
Y
Y
D000208:Acute Disease; D000328:Adult; D016026:Bone Marrow Transplantation / Q000276:immunology*; D002908:Chronic Disease; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use; D003967:Diarrhea / Q000139:chemically induced; D004341:Drug Evaluation; D005260:Female; D006086:Graft vs Host Disease / Q000188:drug therapy*; D006801:Humans; D008297:Male; D016559:Tacrolimus / Q000627:therapeutic use / Q000633:toxicity*; D014184:Transplantation, Homologous
D016572:Cyclosporine; D016559:Tacrolimus